DCN chart, page-66

First 66 Last

Share
Profile

Follow
oodmcoo

125 Posts.

4

20/08/19

16:27

Post #: 40060579
Share

Originally posted by Fengels: ↑

I wouldn't dream of using such profanity. Heaven forbid. I don't quite understand the point you are trying to make though. If you are suggesting DCN might visit 91 cents, I am the last person to reject such a claim. If you have listened to what I have been saying I am of the opinion that this is going to be a turbulent ride until some clear evidence emerges with the price dynamics or in the public announcements made by the company.

I was utterly baffled at the claims that DCN was shooting up like a fella shoving packets of viagra in their mouth and that it would break $1.50 and blow sky high. After the events of the last week or so, the dumb got dumber and rushed into gold shares and the smart got smarter and frightened them to run like little girls with some quite good shorting activity. You should have a look at what those shorters are doing to SAR.

The silly and senseless are always easy to scare and the unthinking are untroubled by reality.

I remain reasonably confident, probably because I am so solidly in the black, that DCN will build. There are a lot of sensible thinking people here who have taken a good look at the company. They deserve recognition and respect for their contributions. They certainly know more about gold mining production than I do. I know next to nothing.

DCN is at the end of the tail of the XGD gold index, when its moves DCN will most probably fly all over the place. But you should have a well-thought out strategy of why you are holding this stock and treat it as a conjecture and not an article of faith.

Just look at the Gold miners today, gosh, this should tell you something.

Expand

Sorry, can you cut in short, is it a good time to buy?

DCN Price at posting: $1.10 Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 473 more messages in this thread...

First 66 Last

Add DCN (ASX) to my watchlist

DCN chart, page-66

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News